CD105 expression has also been described in myelodysplastic syndrome (MDS), acute lymphoblastic leukaemia (ALL) and AML21–23, but its prognostic relevance in these and other haematopoietic malignancies has not been assessed so far. The gene discussed is ENG; the disease is acute lymphoblastic leukemia.